DE69427648D1 - Verfahren zur herstellung einer clodronat-zubereitung - Google Patents

Verfahren zur herstellung einer clodronat-zubereitung

Info

Publication number
DE69427648D1
DE69427648D1 DE69427648T DE69427648T DE69427648D1 DE 69427648 D1 DE69427648 D1 DE 69427648D1 DE 69427648 T DE69427648 T DE 69427648T DE 69427648 T DE69427648 T DE 69427648T DE 69427648 D1 DE69427648 D1 DE 69427648D1
Authority
DE
Germany
Prior art keywords
clodronate
pct
tetrahydrate
disodium
disodium clodronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69427648T
Other languages
English (en)
Other versions
DE69427648T2 (de
Inventor
Esko Pohjala
Heikki Nupponen
Kari Lehmussaari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of DE69427648D1 publication Critical patent/DE69427648D1/de
Application granted granted Critical
Publication of DE69427648T2 publication Critical patent/DE69427648T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Seasonings (AREA)
  • Glanulating (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
  • Glass Compositions (AREA)
DE69427648T 1993-11-12 1994-11-11 Verfahren zur herstellung einer clodronat-zubereitung Expired - Fee Related DE69427648T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (fi) 1993-11-12 1993-11-12 Menetelmä klodronaattivalmisteen valmistamiseksi
PCT/FI1994/000509 WO1995013054A1 (en) 1993-11-12 1994-11-11 Process for preparing a clodronate preparation

Publications (2)

Publication Number Publication Date
DE69427648D1 true DE69427648D1 (de) 2001-08-09
DE69427648T2 DE69427648T2 (de) 2002-04-18

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69427648T Expired - Fee Related DE69427648T2 (de) 1993-11-12 1994-11-11 Verfahren zur herstellung einer clodronat-zubereitung

Country Status (25)

Country Link
US (1) US5776499A (de)
EP (1) EP0727983B1 (de)
JP (1) JPH09504800A (de)
KR (1) KR100352155B1 (de)
CN (1) CN1040945C (de)
AT (1) ATE202700T1 (de)
AU (1) AU679586B2 (de)
CA (1) CA2175994A1 (de)
CZ (1) CZ286132B6 (de)
DE (1) DE69427648T2 (de)
DK (1) DK0727983T3 (de)
ES (1) ES2160688T3 (de)
FI (1) FI94926C (de)
GR (1) GR3036470T3 (de)
HU (1) HU220633B1 (de)
IL (1) IL111596A (de)
NO (1) NO312938B1 (de)
NZ (1) NZ275833A (de)
PL (1) PL176658B1 (de)
PT (1) PT727983E (de)
RU (1) RU2141323C1 (de)
SK (1) SK280552B6 (de)
TW (1) TW436297B (de)
WO (1) WO1995013054A1 (de)
ZA (1) ZA948974B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro) 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) * 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
JP6864955B2 (ja) * 2015-12-22 2021-04-28 ストック カンパニー“チェペトスキー メカニカル プラント” チタン合金から棒材を製造する方法
CA3082728A1 (en) 2017-11-22 2019-05-31 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-maf status
TWI806467B (zh) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 金融商品提昇報酬率多維度決策方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275468B1 (de) * 1986-12-20 1991-02-06 Roche Diagnostics GmbH Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
ES2065313T5 (es) * 1993-05-15 2004-01-01 Roche Diagnostics Gmbh Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.

Also Published As

Publication number Publication date
GR3036470T3 (en) 2001-11-30
HU9601257D0 (en) 1996-07-29
AU679586B2 (en) 1997-07-03
TW436297B (en) 2001-05-28
FI935019A0 (fi) 1993-11-12
EP0727983B1 (de) 2001-07-04
JPH09504800A (ja) 1997-05-13
KR100352155B1 (ko) 2002-12-31
IL111596A0 (en) 1995-01-24
CN1134664A (zh) 1996-10-30
ES2160688T3 (es) 2001-11-16
WO1995013054A1 (en) 1995-05-18
CN1040945C (zh) 1998-12-02
IL111596A (en) 1998-12-06
KR960705548A (ko) 1996-11-08
AU8108794A (en) 1995-05-29
SK60696A3 (en) 1997-02-05
NZ275833A (en) 1997-10-24
PL314299A1 (en) 1996-09-02
CZ132796A3 (en) 1996-10-16
DE69427648T2 (de) 2002-04-18
NO312938B1 (no) 2002-07-22
HUT75228A (en) 1997-04-28
FI94926C (fi) 1995-11-27
PT727983E (pt) 2001-11-30
SK280552B6 (sk) 2000-03-13
HU220633B1 (hu) 2002-03-28
DK0727983T3 (da) 2001-09-24
CZ286132B6 (cs) 2000-01-12
ATE202700T1 (de) 2001-07-15
CA2175994A1 (en) 1995-05-18
FI94926B (fi) 1995-08-15
NO961906D0 (no) 1996-05-10
PL176658B1 (pl) 1999-07-30
US5776499A (en) 1998-07-07
NO961906L (no) 1996-05-23
FI935019A (fi) 1995-05-13
EP0727983A1 (de) 1996-08-28
ZA948974B (en) 1995-11-21
RU2141323C1 (ru) 1999-11-20

Similar Documents

Publication Publication Date Title
ATE183641T1 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
DE69112463D1 (de) Vorrichtung zur Herstellung von Monokristallen nach dem Czochralski-Verfahren.
NO971965L (no) Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
DE69016521D1 (de) Verfahren zur Herstellung von Dialkylethern.
ATE236639T1 (de) Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
DE69017642D1 (de) Vorrichtung zur Herstellung von Einkristallen nach dem Czochralski-Verfahren.
DE69427648D1 (de) Verfahren zur herstellung einer clodronat-zubereitung
PT98422A (pt) Processo de fabricacao d vaterite, de um derivado calcio, de mistura de vaterites e de vaterite revestida
ATE152476T1 (de) Verfahren zur herstellung von granulaten
NO960972L (no) Leirdue og en fremgangsmåte for fremstilling av denne
ATE161423T1 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE69108007D1 (de) Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
HUT49793A (en) Herbicide compositions containing n-aryl-tetrahydro-phtalimides as active components and process for producing the active components
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE68924373D1 (de) Verfahren zur Herstellung konzentrierter Granulatkörner von oberflächenaktiven Mitteln.
HUT52763A (en) Herbicide and growth-controlling compositions containing sulfonyl-urea derivatives as active components and process for producing the active components
IL91986A0 (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
JPS51151743A (en) Process for preparing shaped polyester article
HUT45533A (en) Process for producing s541-antibiotica and veterinary compositions containing them as active components, and compositions against parasites of plants containing them as active components
JPS57170165A (en) Active calcium fortifier
HUT59903A (en) Fungicide compositions containing oxime-carbamates as active components and process for producing the active components
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
DE69428210D1 (de) Verfahren zur herstellung von körnigen alkalinitrilotriacetat
SU1601940A1 (ru) Способ получения искусственного карналлита
ATA142698A (de) Verfahren zur herstellung eines schaumstoffes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee